The Chronic antiplatelet therapy in prevetion of cardiovascular diseases (in population of elderly) from the perspective of oral health: Cardiologic safety versus complications risk. Influence of oral diseases on global health risk in elderly
DOI:
https://doi.org/10.12775/JEHS.2023.20.01.012Keywords
Platelet Aggregation Inhibitors, Frailty, hemorrhage, Hemostasis, Chronic DiseaseAbstract
Introduction and purpose: Oral cavity diseases are a common problem in everyday clinical practice, particularly important in the context of elderly people affected by numerous chronic diseases, on the verge of frailty. These patients are often characterized by an increased risk of cardiovascular events, but also an increased risk of bleeding, which is the reason for dentists' doubts regarding the maintenance or suspension of chronic antiplatelet therapy in the periprocedural period. The aim of our work is to present the risks of untreated oral diseases and to summarize the current knowledge and recommendations on the use of antiplatelet drugs during surgical dental treatment.
Description of the state of knowledge: It has been proven that the ongoing disease processes in the oral cavity exacerbate the course of chronic diseases by several different mechanisms, the best known of which are: opening the gates to the bloodstream, blood circulation of inflammatory mediators and direct colonization of the respiratory tract by microorganisms from the focal point in the oral cavity. According to current research, standard dental surgeries can be safely performed in patients taking antiplatelet drug(s) chronically without the need to discontinue therapy in the periprocedural period. The risk of prolonged or excessive bleeding in such patients is not significantly increased, and bleeding complications that occur can be managed with local haemostasis measures.
Conclusions: Prevention and early treatment of oral diseases can protect against their negative global impact on health. There is no indication to interrupt chronic antiplatelet therapy with one or two drugs prior to standard dental procedures.
References
World report on Ageing And HeAltH. Published online 2015. Accessed March 29, 2023. www.who.int
Krishnan B, Shenoy NA, Alexander M. Exodontia and antiplatelet therapy. J Oral Maxillofac Surg. 2008;66(10):2063-2066. doi:10.1016/J.JOMS.2008.06.027
Shenoy A, Panicker P, Vijayan A, George AL. Prospective Comparative Evaluation of Post-extraction Bleeding in Cardiovascular-Compromised Patients with and without Antiplatelet Medications. J Maxillofac Oral Surg. 2021;20(3):486-495. doi:10.1007/S12663-019-01315-9
Oral Anticoagulant and Antiplatelet Medications and Dental Procedures | American Dental Association. Accessed April 22, 2023. https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/oral-anticoagulant-and-antiplatelet-medications-and-dental-procedures
Rossini R, Musumeci G, Capodanno D, et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Thromb Haemost. 2015;113(2):272-282. doi:10.1160/TH14-05-0436
Redfors B, Kirtane AJ, Liu M, et al. Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022;15(8):797-806. doi:10.1016/J.JCIN.2022.01.300
Doganay O, Atalay B, Karadag E, Aga U, Tugrul M. Bleeding frequency of patients taking ticagrelor, aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction and minor oral surgery. J Am Dent Assoc. 2018;149(2):132-138. doi:10.1016/J.ADAJ.2017.09.052
Schreuder WH, Peacock ZS. Antiplatelet therapy and exodontia. J Am Dent Assoc. 2015;146(11):851-856. doi:10.1016/J.ADAJ.2015.04.024
Li L, Zhang W, Yang Y, Zhao L, Zhou X, Zhang J. Dental management of patient with dual antiplatelet therapy: a meta-analysis. Clin Oral Investig. 2019;23(4):1615-1623. doi:10.1007/S00784-018-2591-Y
Bajkin B V., Urosevic IM, Stankov KM, Petrovic BB, Bajkin IA. Dental extractions and risk of bleeding in patients taking single and dual antiplatelet treatment. Br J Oral Maxillofac Surg. 2015;53(1):39-43. doi:10.1016/J.BJOMS.2014.09.009
Shenoy A, Panicker P, Vijayan A, George AL. Prospective Comparative Evaluation of Post-extraction Bleeding in Cardiovascular-Compromised Patients with and without Antiplatelet Medications. J Maxillofac Oral Surg. 2021;20(3):486-495. doi:10.1007/S12663-019-01315-9
Offermanns S. Activation of Platelet Function Through G Protein-Coupled Receptors. Published online 2006. doi:10.1161/01.RES.0000251742.71301.16
Montinari MR, Minelli S, De Caterina R. The first 3500 years of aspirin history from its roots - A concise summary. Vascul Pharmacol. 2019;113:1-8. doi:10.1016/J.VPH.2018.10.008
Jeffreys Diarmuid, Recorded Books Inc. Aspirin : the Remarkable Story Of A Wonder Drug. Published online 2008. Accessed March 12, 2023. https://web.archive.org/web/20181124232342/https://books.google.com/books/about/Aspirin.html?hl=de&id=a9gkBwAAQBAJ
RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2. The Lancet. 1988;332(8607):349-360. doi:10.1016/S0140-6736(88)92833-4
Théroux P, Ouimet H, McCans J, et al. Aspirin, Heparin, or Both to Treat Acute Unstable Angina. New England Journal of Medicine. 1988;319(17):1105-1111. doi:10.1056/NEJM198810273191701
Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSThe Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European As. Eur Heart J. 2018;39(3):213-260. doi:10.1093/EURHEARTJ/EHX419
McNeil JJ, Wolfe R, Woods RL, et al. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. New England Journal of Medicine. 2018;379(16):1509-1518. doi:10.1056/NEJMoa1805819
McNeil JJ, Woods RL, Nelson MR, et al. Effect of Aspirin on Disability-free Survival in the Healthy Elderly. N Engl J Med. 2018;379(16):1499-1508. doi:10.1056/NEJMOA1800722
Wytyczne ESC dotyczące prewencji chorób układu sercowo-naczyniowego w praktyce klinicznej. Accessed March 16, 2023. https://ptkardio.pl/wytyczne/14-wytyczne_esc_dotyczace_prewencji_chorob_ukladu_sercowo_naczyniowego_w_praktyce_klinicznej
Wytyczne ESC 2021 dotyczące prewencji chorób układu secowo-naczyniowego w praktyce klinicznej. Accessed March 16, 2023. https://ptkardio.pl/wytyczne/42-wytyczne_esc_2021_dotyczace_prewencji_chorob_ukladu_secowo_naczyniowego_w_praktyce_klinicznej
Grimm R, McNeil JJ, Applegate W, et al. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial. Contemp Clin Trials. 2013;36(2):555-564. doi:10.1016/J.CCT.2013.09.014
Gabryś T, Bajorek A, Malinowska-Lipień I. Zespół słabości – zasadniczy problem zdrowotny osób starszych. Częœć I. Gerontologia Polska 2015, 1, 29-33. 2015;1:29-33.
Walston J, Hadley EC, Ferrucci L, et al. Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54(6):991-1001. doi:10.1111/J.1532-5415.2006.00745.X
Pilotto A, Custodero C, Maggi S, Polidori MC, Veronese N, Ferrucci L. A multidimensional approach to frailty in older people. Ageing Res Rev. 2020;60:101047. doi:10.1016/J.ARR.2020.101047
Lee H, Lee E, Jang IY. Frailty and Comprehensive Geriatric Assessment. J Korean Med Sci. 2020;35(3). doi:10.3346/JKMS.2020.35.E16
Morley JE, Vellas B, Abellan van Kan G, et al. Frailty Consensus: A Call to Action. J Am Med Dir Assoc. 2013;14(6):392. doi:10.1016/J.JAMDA.2013.03.022
Avila M, Ojcius DM, Yilmaz Ö. The Oral Microbiota: Living with a Permanent Guest. DNA Cell Biol. 2009;28(8):405. doi:10.1089/DNA.2009.0874
Scannapieco FA. The oral microbiome: Its role in health and in oral and systemic infections. Clin Microbiol Newsl. 2013;35(20):163-169. doi:10.1016/J.CLINMICNEWS.2013.09.003
ThayerW. Thayer: Studies on bacterial (infective) endocarditis - Google Scholar. Studies on bacterial (infective) endocarditis. Johns Hopkins Hosp Rep. 1926. Published 1926. Accessed April 10, 2023. https://scholar.google.com/scholar_lookup?journal=Johns+Hopkins+Hosp+Rep&title=Studies+on+bacterial+(infective)+endocarditis&author=WS+Thayer&volume=22&publication_year=1926&pages=1-8&
Meurman JH, Bascones-Martinez A. Oral Infections and Systemic Health-More than Just Links to Cardiovascular Diseases. doi:10.3290/j.ohpd.b1993965
Sabharwal A, Stellrecht E, Scannapieco FA. Associations between dental caries and systemic diseases: a scoping review. BMC Oral Health. 2021;21(1). doi:10.1186/S12903-021-01803-W
Di Stefano M, Polizzi A, Santonocito S, Romano A, Lombardi T, Isola G. Impact of Oral Microbiome in Periodontal Health and Periodontitis: A Critical Review on Prevention and Treatment. Int J Mol Sci. 2022;23(9). doi:10.3390/IJMS23095142
Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47 Suppl 22(Suppl 22):4-60. doi:10.1111/JCPE.13290
Möller B, Bender P, Eick S, et al. Treatment of severe periodontitis may improve clinical disease activity in otherwise treatment-refractory rheumatoid arthritis patients. Rheumatology (Oxford). 2020;59(1):243. doi:10.1093/RHEUMATOLOGY/KEZ287
Jańczuk Z. Stomatologia Zachowawcza Zarys Kliniczny. Wydawnictwo Lekarskie PZWL; 2002.
Botelho MPJ, MacIel SM, Cerci Neto A, Dezan CC, Fernandes KBP, De Andrade FB. Cariogenic microorganisms and oral conditions in asthmatic children. Caries Res. 2011;45(4):386-392. doi:10.1159/000330233
Ergöz N, Seymen F, Gencay K, et al. Genetic Variation in Ameloblastin Is Associated with Caries in Asthmatic Children. Eur Arch Paediatr Dent. 2014;15(3):211. doi:10.1007/S40368-013-0096-6
Cardoso AMR, Gomes LN, Silva CRD, et al. Dental caries and periodontal disease in Brazilian children and adolescents with cerebral palsy. Int J Environ Res Public Health. 2014;12(1):335-353. doi:10.3390/IJERPH120100335
Paszynska E, Dmitrzak-Węglarz M, Perczak A, et al. Excessive Weight Gain and Dental Caries Experience among Children Affected by ADHD. Int J Environ Res Public Health. 2020;17(16):1-12. doi:10.3390/IJERPH17165870
Bartlett D, O’Toole S. Tooth wear and aging. Aust Dent J. 2019;64(S1):S59-S62. doi:10.1111/ADJ.12681
Bartlett D. A new look at erosive tooth wear in elderly people. J Am Dent Assoc. 2007;138 Suppl(9 SUPPL.):S21-S25. doi:10.14219/JADA.ARCHIVE.2007.0356
Loomans B, Opdam N, Attin T, et al. Severe Tooth Wear: European Consensus Statement on Management Guidelines. J Adhes Dent. 2017;19(2):111-119. doi:10.3290/J.JAD.A38102
Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: A randomized, controlled clinical trial. Br J Anaesth. 2010;104(3):305-312. doi:10.1093/bja/aeq003
Rossini R, Capodanno D, Lettieri C, et al. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. American Journal of Cardiology. 2011;107(2):186-194. doi:10.1016/j.amjcard.2010.08.067
Václavík J, Táborský M. Antiplatelet therapy in the perioperative period. Eur J Intern Med. 2011;22(1):26-31. doi:10.1016/j.ejim.2010.10.007
Campos N de, Furlaneto F, Buischi YDP, Campos N de, Furlaneto F, Buischi YDP. Bleeding in Dental Surgery. Contemporary Applications of Biologic Hemostatic Agents across Surgical Specialties - Volume 2 [Working Title]. Published online November 6, 2019. doi:10.5772/INTECHOPEN.89992
Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(Suppl 22):4. doi:10.1111/JCPE.13290
Passarelli PC, Pagnoni S, Piccirillo GB, et al. Reasons for Tooth Extractions and Related Risk Factors in Adult Patients: A Cohort Study. Int J Environ Res Public Health. 2020;17(7). doi:10.3390/IJERPH17072575
Tooth Wear Guidelines for the BSRD. Accessed April 22, 2023. www.dentsplysirona.com/pbactiveuk
Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost. 2016;14(5):875-885. doi:10.1111/JTH.13305
Kaplovitch E, Dounaevskaia V. Treatment in the dental practice of the patient receiving anticoagulation therapy. J Am Dent Assoc. 2019;150(7):602-608. doi:10.1016/J.ADAJ.2019.02.011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Marta Wychota, Jan Bieniasz, Konrad Dendys, Marcel Kazzi, Michał Puła
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 298
Number of citations: 0